TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Hepatic APCs play a critical role in promoting immune tolerance in the liver. Recently, we have demonstrated that TLR2 stimulation on liver sinusoidal endothelial cells reverted their suppressive properties to induce T cell immunity. However, there is a paucity of information about how TLR2 stimulation modulates the immunological function of other hepatic APCs. In the current study, we investigated whether TLR2 stimulation influences the function of intrahepatic myeloid-derived cells (iMDCs) and elucidated the mechanisms involved in iMDC-induced T cell immunity. We could show that iMDCs from C57BL/6 mice can potently suppress T cell activation in a cell contact–independent manner. Ag presentation by iMDCs leads to naive CD8 T cell tolerance. To our surprise, instead of inducing cell functional maturation, TLR2 ligand palmitoyl-3-cysteine-serine-lysine-4 (P3C) stimulation further strengthens the suppressive and tolerogenic properties of iMDCs. After P3C administration, the population of Kupffer cells (KCs) of iMDCs dramatically increased. Mechanism analysis shows that KCs are essential for the enhanced inhibition of T cell activation by P3C-stimulated iMDCs. The iMDC-mediated CD8 T cell inhibition was mediated by soluble mediators, one of which was IL-10 secreted by KCs after P3C stimulation. IL-10 blockade could partially abolish iMDC-mediated T cell inhibition. Moreover, hepatitis B virus particle stimulation on iMDCs could also induce IL-10 production by the cells in a TLR2-dependent way. Our results have implications for our understanding of liver-specific tolerance and for the development of strategies to overcome T cell tolerance in situations such as chronic viral liver infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In turn, Kupffer cells release IL-10 to induce T-cell immunotolerance [300].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [300]
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“TLRs, as a group of highly conserved molecules, play a major role in the recognition of pathogen-associated molecular patterns and host defense against various infectious microorganisms (14).”
BackgroundAkira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 2×
“It can suppress cytokine production and proliferation of CD4 and CD8 T cells via the IL-10/IL-10R pathway (51).”
BackgroundDifferentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · cited 8×
“Under steady-state conditions, KCs can stimulate the suppressive activity of regulatory T cells (Tregs) through inducing IL-10 production by Tregs, which is crucial for the induction of tolerance to hepatocyte-expressed Ags (30).”
BackgroundInfluentialThe regulation of IL-10 production by immune cells
Saraiva, M., & O'Garra, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2711 · Cited by 3,164
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805
The role of myeloid cells in cancer therapies
Engblom, C., Pfirschke, C., & Pittet, M. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.54 · Cited by 788
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758
Agrawal, S., Agrawal, A., Doughty, B., Gerwitz, A., Blenis, J., Van Dyke, T., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.4984 · Cited by 725
Cited by
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Costa Verdera, H., Kuranda, K., & Mingozzi, F. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.12.010 · Cited by 641
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
Ronzitti, G., Gross, D.-A., & Mingozzi, F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00670 · Cited by 357
Yan, Y., Chen, R., Wang, X., Hu, K., Huang, L., Lu, M., & Hu, Q. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00212 · Cited by 187
Self-citationFisicaro, P., Barili, V., Rossi, M., Montali, I., Vecchi, A., Acerbi, G., Laccabue, D., Zecca, A., Penna, A., Missale, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00849 · Cited by 160
Zheng, W., Song, H., Luo, Z., Wu, H., Chen, L., Wang, Y., Cui, H., Zhang, Y., Wang, B., Li, W., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017762118 · Cited by 109
Self-citation(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
The Role of Myeloid-Derived Cells in the Progression of Liver Disease
Weston, C. J., Zimmermann, H. W., & Adams, D. H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00893 · Cited by 95
The critical role of Toll-like receptor-mediated signaling in cancer immunotherapy
Chen, X., Zhang, Y., & Fu, Y. S. (2022) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2022.100122 · Cited by 94
Li, Q., Yan, Y., Liu, J., Huang, X., Zhang, X., Kirschning, C. J., Xu, H. C., Lang, P. A., Dittmer, U., Zhang, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02191 · Cited by 87
Self-citationCrosstalk network among multiple inflammatory mediators in liver fibrosis
Zhangdi, H., Su, S.-B., Wang, F., Liang, Z., Yan, Y.-D., Qin, S., & Jiang, H.-X. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i33.4835 · Cited by 78
Ariel, O., Gendron, D., Dudemaine, P.-L., Gévry, N. Y., Ibeagha-Awemu, E. M., & Bissonnette, N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02874 · Cited by 83
Zheng, P., Dou, Y., & Wang, Q. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1206720 · Cited by 78
Yang, S., Wang, L., Pan, W., Bayer, W., Thöns, C., Heim, K., Dittmer, U., Timm, J., Wang, Q., Yu, Q., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.013 · Cited by 57
Self-citationMacrophages as key regulators of liver health and disease
Papachristoforou, E., & Ramachandran, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.006 · Cited by 70
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in mice
Thomas, S. K., Wattenberg, M. M., Choi-Bose, S., Uhlik, M. T., Harrison, B., Coho, H., Cassella, C. R., Stone, M. L., Patel, D. G., Markowitz, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41771-z · Cited by 58
Hepatitis B virus infection: Defective surface antigen expression and pathogenesis
Wu, C., Chen, Y., Cao, L., Chen, X., & Lu, M. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i31.3488 · Cited by 57
Self-citationThe curious case of AAV immunology
Keeler, A. M., Zhan, W., Ram, S., Fitzgerald, K. A., & Gao, G. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.037 · Cited by 52
Zhang, E., Ma, Z., Li, Q., Yan, H., Liu, J., Wu, W., Guo, J., Zhang, X., Kirschning, C. J., Xu, H. C., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900065 · Cited by 41
Self-citationToll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
Du, Y., Wu, J., Liu, J., Zheng, X., Yang, D., & Lu, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965018 · Cited by 40
Self-citationCCL19 enhances CD8+ T-cell responses and accelerates HBV clearance
Yan, Y., Zhao, W., Liu, W., Li, Y., Wang, X., Xun, J., & Davgadorj, C. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01799-8 · Cited by 44
Lin, Y., Huang, X., Wu, J., Liu, J., Chen, M., Ma, Z., Zhang, E., Liu, Y., Huang, S., Li, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01495 · Cited by 30
Self-citationInterorgan communication with the liver: novel mechanisms and therapeutic targets
Zhao, J., Zhang, X., Li, Y., Yu, J., Chen, Z., Niu, Y., Ran, S., Wang, S., Ye, W., Luo, Z., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1314123 · Cited by 31
Mechanisms of Interleukin-10-Mediated Immunosuppression in Viral Infections
Guo, Z., He, Q., Zhang, Y., Li, Y., & Zhang, Z. (2025) · Pathogens · doi:10.3390/pathogens14100989 · Cited by 35
Zhang, E., Ma, Z., & Lu, M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04582-x · Cited by 28
Self-citationWang, H., Li, L., Li, Y., Li, Y., Sha, Y., Wen, S., You, Q., Liu, L., Shi, M., & Zhou, H. (2020) · Theranostics · doi:10.7150/thno.51369 · Cited by 26
Zhou, W., Luo, J., Xie, X., Yang, S., Zhu, D., Huang, H., Yang, D., & Liu, J. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00161 · Cited by 24
Self-citationHepatitis B virus particles activate B cells through the TLR2–MyD88–mTOR axis
Li, Q., Wang, J., Islam, H., Kirschning, C. J., Lu, H., Hoffmann, D. E., Dittmer, U., & Lu, M. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03284-1 · Cited by 19
Self-citationPlasticity of monocytes and macrophages in cirrhosis of the liver
Geng, A., Flint, E., & Bernsmeier, C. (2022) · Frontiers in Network Physiology · doi:10.3389/fnetp.2022.937739 · Cited by 19
Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection
Yan, Y., Qiu, Y., Davgadorj, C., & Zheng, C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.847539 · Cited by 20
Innate immune recognition in hepatitis B virus infection
Li, A., Zhengjun, Y., Ma, C., Sun, B., Zhao, L. Y., Cheng, X., Hui, L., & Xia, Y. (2025) · Virulence · doi:10.1080/21505594.2025.2492371 · Cited by 28
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 16
TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome
Naghib, M., Kariminik, A., & Arababadi, M. K. (2022) · Viral Immunology · doi:10.1089/vim.2021.0141 · Cited by 14
TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+ T cells
Yan, H., Zhong, M., Yang, J., Guo, J., Yu, J., Yang, Y., Ma, Z., Zhao, B., Zhang, Y., Wang, J., et al. (2020) · Immunology · doi:10.1111/imm.13251 · Cited by 14
Self-citationLiver Macrophage Diversity in Health and Disease
Horn, P., & Tacke, F. (2024) · Results and problems in cell differentiation · doi:10.1007/978-3-031-65944-7_7 · Cited by 17
Navigating immune cell immunometabolism after liver transplantation
Zhang, W., Liu, Z., & Xu, X. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103227 · Cited by 15
Xie, X., Luo, J., Zhu, D. Y., Zhou, W., Yang, X., Feng, X., Lu, M., Zheng, X., Dittmer, U., Yang, D., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.797915 · Cited by 11
Self-citationZhang, E., Yan, H., Li, Q., Dittmer, U., Yan, H., & Lu, M. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0255-8 · Cited by 9
Self-citationWang, J., Lu, H., & Li, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1414594 · Cited by 9
Broering, R., Luo, X., Liu, J., & Lu, M. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00235-0 · Cited by 6
Self-citationViral vectors in neurodegenerative diseases: immune responses and therapeutic applications
Wang, Y., Mu, S., & Liu, F. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1603125 · Cited by 7
Du, Y., Zhao, M., Zeng, X., Wang, S., Wang, Q., Chen, L., Yang, X., Feng, X., Lu, M., Dittmer, U., et al. (2025) · Medical Microbiology and Immunology · doi:10.1007/s00430-025-00834-2 · Cited by 3
Self-citationTherapeutic targeting of myeloid cells in liver fibrosis: Mechanisms and clinical prospects
Wang, Y., Liu, Y., Chen, D., Liu, L., Sun, L., & Zhang, L. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70053 · Cited by 5
Illuminating HBV with multi-scale modeling
Means, S., Ali, M. A., & Ho, H. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1045754 · Cited by 3
Perspectives on TLR2 agonist use in the road map to HBV cure
Pieterman, R. F. A., Durantel, D., Janssen, H. L. A., Sprengers, D., & Buschow, S. I. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106447 · Cited by 1
Resposta imune-inflamatória a agentes infecciosos no microambiente hepático de cães e gatos: revisão
Ferreira, T. M. V., & Nunes‐Pinheiro, D. C. S. (2019) · PubVet · doi:10.31533/pubvet.v13n9a401.1-11
Hsu, C., Jasim, S. A., Rasool, K. H., Malathi, H., Kaur, J., Jabir, M. S., Alhajlah, S., Kumar, A., Jawad, S. F., & Husseen, B. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152344
Prospects for leveraging knowledge on ISG and NF-kB effector functions into anti-HBV therapies
Zhao, K., & Xia, Y. (2026) · Antiviral Research · doi:10.1016/j.antiviral.2026.106397
Verdera, H. C. (2019) · theses.fr (ABES) · doi:10.70675/3d2d8524z211ez4408zbdfbz56c065f452a1
Etude des réponses T CD8+ après transfert de gène par rAAV ciblant le muscle
Jeanpierre, L. (2024) · theses.fr (ABES) · doi:10.70675/430aceacz50d2z426bz907dz876c55d1e935
Macrophages in oncoviral infections: from immune regulators to therapeutic targets
Sang, R., Zhang, Q., Wang, F., Liu, W., & Zhang, Y. (2026) · Inflammation Research · doi:10.1007/s00011-026-02284-9
Metadata
- Authors
- Liu, J., Yu, Q., Wu, W., Huang, X., Broering, R., Werner, M., Roggendorf, M., Yang, D., & Lu, M.
- Affiliations
- Essen University Hospital (DE)
- Wuhan Union Hospital (CN)
- Corresponding author
- Liu, Jia
- Wu, Weimin
- Huang, Xuan
- Roggendorf, Michael
- Lu, Mengji
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-01
- Volume
- 200
- Issue
- 7
- Pages
- 2341-2351
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2788398088
- Cited by
- 50
- References
- 52
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 3 · 2023: 4 · 2022: 8 · 2021: 5 · 2020: 7 · 2019: 9 · 2018: 2
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Funders
- Universität Duisburg-Essen
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TLR2, myeloid-derived cells, Kupffer cells, T cell tolerance, IL-10, CD8+ T cell suppression, hepatitis B virus, liver sinusoidal endothelial cells
- MeSH terms
- Animals, Cells, Cultured, Female, Hepatitis B virus, Humans, Immune Tolerance, Interferon-gamma, Kupffer Cells, Liver, Lymphocyte Activation, Mice, Inbred C57BL, Mice, Transgenic, T-Lymphocytes, Interleukin-10, Antigen Presentation, Cell Proliferation, Toll-Like Receptor 2, Mice, Lipopeptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.